US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
イギリス
LSE
XSpray Pharma AB (0GHZ) 銘柄情報

XSpray Pharma AB (0GHZ)

78.80

0.00

(0.00%)

終了 6月12日 12:30AM

XSpray Pharma AB (0GHZ) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

78.80

( - )

買値

78.80

売値

78.80

出来高

410

0.00 日の範囲 0.00

78.80 52 週間の範囲 78.80

時価総額

前日終値

78.80

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

SEK 119,000

発行済株式数

47,416,574

配当利回り

PER

-4.28

1 株当たり利益 (EPS)

-4.16

歳入

2.47M

純利益

-164.51M

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS... Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partnership agreements with EVERSANA for the commercialization of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.xspraypharma.com

本社

Solna, Sweden

設立

2026

XSpray Pharma AB is listed in the sector of the ロンドン証券取引所 with ticker 0GHZ. The last closing price for XSpray Pharma AB was SEK78.80. Over the last year, XSpray Pharma AB shares have traded in a share price range of SEK 78.80 to SEK 78.80.

XSpray Pharma AB currently has 47,416,574 shares in issue. The market capitalisation of XSpray Pharma AB is SEK3.74 billion. XSpray Pharma AB has a price to earnings ratio (PE ratio) of -4.28.

Notice of Extraordinary General Meeting in Xspray Pharma AB (publ)

Notice of Extraordinary General Meeting in Xspray Pharma AB (publ) PR Newswire STOCKHOLM, Jan. 31, 2018 STOCKHOLM, Jan. 31, 2018 /PRNewswire/...

Notice of Extraordinary General Meeting in Xspray Pharma AB (publ)

Notice of Extraordinary General Meeting in Xspray Pharma AB (publ) PR Newswire STOCKHOLM, Jan. 31, 2018 STOCKHOLM, Jan. 31, 2018 /PRNewswire/...

XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Produ...

XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Product Portfolio PR...

XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Produ...

XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Product Portfolio PR...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	78.8	78.8	78.8	144	78.8	DE
52	0	0	78.8	78.8	78.8	441	78.8	DE
156	0	0	78.8	78.8	78.8	174	78.8	DE
260	0	0	78.8	78.8	78.8	107	78.8	DE

0GHZ - Frequently Asked Questions (FAQ)

What is the current XSpray Pharma AB share price?

The current share price of XSpray Pharma AB is SEK 78.80

How many XSpray Pharma AB shares are in issue?

XSpray Pharma AB has 47,416,574 shares in issue

What is the market cap of XSpray Pharma AB?

The market capitalisation of XSpray Pharma AB is SEK 3.74B

What is the 1 year trading range for XSpray Pharma AB share price?

XSpray Pharma AB has traded in the range of SEK 78.80 to SEK 78.80 during the past year

What is the PE ratio of XSpray Pharma AB?

The price to earnings ratio of XSpray Pharma AB is -4.28

What is the cash to sales ratio of XSpray Pharma AB?

The cash to sales ratio of XSpray Pharma AB is 342.26

What is the registered address of XSpray Pharma AB?

The registered address for XSpray Pharma AB is Scheeles väg 2, Solna, Stockholm County, 171 65

What is the XSpray Pharma AB website address?

The website address for XSpray Pharma AB is www.xspraypharma.com

nowwhat2

nowwhat2 4分前

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dlvrrsilver_june_11_3y_w_asian_guy.jpg

nowwhat2

nowwhat2 5分前

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dlvrrsilver_june_11_3y_w_asian_guy.jpg

axelvento

axelvento 5分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 13分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 14分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 17分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 18分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 23分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 24分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 26分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 29分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 30分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 30分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 32分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 33分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 33分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 36分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 37分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Lord Andreti

Lord Andreti 38分前

It’s far from going to no bid. Bid is high AF right now and not something you see daily around the OTC market.

Something is brewing and this is for sure going places (bid still gives the biggest tells)…I just don’t think it’s going be that big of a deal, anymore, after this crap.

OMOLIVES

OMOLIVES 38分前

Also, look at the past six Months. They had 7.5 - 1 Billion volume days over the past six Months. Backlog, bottleneck....fucked.

XSpray Pharma AB

1.25% TREASURY GILT 22/1...

Reynolds Consumer Products

Ariston Holding NV (PK)

Tuga Innovations

Altitude Acquisition

Exploits Discovery

Battery X Metals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。